Mega Genomics LimitedHKEX: 6667

Continuing connected transactions - renewal of the meinian cooperation framework agreement and the dr. yu cooperation framework agreement

· Issued by Mega Genomics Limited via HKEXnews

Filed with HKEX · Stock code 6667 · · 17 pages · English

Summary by 6ix AI

Mega Genomics Limited has filed a document regarding the renewal of the Meinian Cooperation Framework Agreement and the Dr. Yu Cooperation Framework Agreement, which are continuing connected transactions with controlling shareholders. The agreements outline the provision of testing services and related products to Meinian OneHealth and Dr. Yu, with proposed annual caps for the transactions over the next few years. The filing also discusses the implications under listing rules, including the need for independent shareholder approval due to the nature of the transactions. The company has established an Independent Board Committee to advise on the agreements and ensure compliance with regulatory requirements.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Mega Genomics Limited on 6ix

Earlier from Mega Genomics

Later from Mega Genomics

All Mega Genomics news releases